<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01513759</url>
  </required_header>
  <id_info>
    <org_study_id>EKOS 09</org_study_id>
    <nct_id>NCT01513759</nct_id>
  </id_info>
  <brief_title>A Prospective, Single-arm, Multi-center Trial of EkoSonic® Endovascular System and Activase for Treatment of Acute Pulmonary Embolism (PE).</brief_title>
  <acronym>SEATTLE II</acronym>
  <official_title>Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EKOS Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EKOS Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the EKOS EkoSonic® Endovascular Device when used
      in conjunction with recombinant t-PA as a treatment for acute pulmonary embolism (PE) will
      decrease the ratio of RV to LV diameter within 48 ± 6 hours in patients with massive or
      submassive PE.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>RV to LV Diameter Ratio</measure>
    <time_frame>Baseline and 48 ± 6 hours after Baseline</time_frame>
    <description>Determine whether treatment with ultrasound-accelerated catheter-directed fibrinolysis will significantly decrease the ratio of RV to LV diameter within 48 ± 6 hours in patients with massive or submassive PE.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Bleeding</measure>
    <time_frame>Within 72 hours of treatment initiation</time_frame>
    <description>Determine the frequency of major bleeding within 72 hours of initiation of the ultrasound-accelerated catheter-directed fibrinolysis procedure in patients with massive or submassive PE.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Pulmonary Embolism</condition>
  <condition>Acute Pulmonary Embolism</condition>
  <condition>Sub-massive Pulmonary Embolism</condition>
  <condition>Massive Pulmonary Embolism</condition>
  <condition>Pulmonary Thromboembolism</condition>
  <arm_group>
    <arm_group_label>EkoSonic Treatment Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive 24 mg of recombinant tissue plasminogen activator delivered through the EkoSonic Endovascular System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>recombinant tissue plasminogen activator</intervention_name>
    <description>Patients receive 24 mg of recombinant tissue plasminogen activator delivered via the EkoSonic Endovascular Device.</description>
    <arm_group_label>EkoSonic Treatment Arm</arm_group_label>
    <other_name>rt-PA</other_name>
    <other_name>t-PA</other_name>
    <other_name>Alteplase</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EKOS EkoSonic Endovascular System</intervention_name>
    <description>24 mg of recombinant tissue plasminogen activator delivered through the EkoSonic Endovascular System.</description>
    <arm_group_label>EkoSonic Treatment Arm</arm_group_label>
    <other_name>EkoSonic Endovascular Device</other_name>
    <other_name>EkoSonic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alteplase</intervention_name>
    <description>Patients receive 24 mg of alteplase delivered via the EkoSonic Endovascular Device</description>
    <arm_group_label>EkoSonic Treatment Arm</arm_group_label>
    <other_name>EkoSonic Endovascular System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CT evidence of proximal PE (filling defect in at least one main or segmental pulmonary
             artery) AND

          -  Age ≥ 18 years AND

          -  PE symptom duration ≤14 days AND

          -  Informed consent can be obtained from subject or Legally Authorized Representative
             (LAR) AND

          -  Massive PE (syncope, systemic arterial hypotension, cardiogenic shock, or resuscitated
             cardiac arrest) OR

          -  Submassive PE (RV diameter-to-LV diameter ≥ 0.9 on contrast-enhanced chest CT)

        Exclusion Criteria:

          -  Stroke or transient ischemic attack (TIA), head trauma, or other active intracranial
             or intraspinal disease within one year

          -  Recent (within one month) or active bleeding from a major organ

          -  Hematocrit &lt; 30%

          -  Platelets &lt; 100 thousand/μL

          -  INR &gt; 3

          -  aPTT &gt; 50 seconds on no anticoagulants

          -  Major surgery within seven days

          -  Serum creatinine &gt; 2 mg/dL

          -  Clinician deems high-risk for catastrophic bleeding

          -  History of heparin-induced thrombocytopenia (HIT)

          -  Pregnancy

          -  Catheter-based pharmacomechanical treatment for pulmonary embolism within 3 days of
             study enrollment

          -  Systolic blood pressure less than 80 mm Hg despite vasopressor or inotropic support

          -  Cardiac arrest (including pulseless electrical activity and asystole) requiring active
             cardiopulmonary resuscitation (CPR)

          -  Evidence of irreversible neurological compromise

          -  Life expectancy &lt; 30 days

          -  Use of thrombolytics or glycoprotein IIb/IIIa antagonists within 3 days prior to
             inclusion in the study

          -  Previous enrollment in the SEATTLE study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Narinder Bhalla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baptist Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Kuo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford Hospital and Clinics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen K Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Medical Center - Modesto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Immad Sidiq, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hartford Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samuel Z Goldhaber, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Brigham and Women's</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark J Garcia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christiana Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rohit Bhatheja, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Florida Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Kennedy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Holmes Regional Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fakhir Elmasri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lakeland Regional Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barry S Weinstock, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orlando Regional Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Ayerdi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Center of Central Georgia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nilesh Goswami, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prairie Heart Institute - St.John's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kannan Natarajan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Vincent's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tod C Engelhardt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>East Jefferson General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Kumar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Overlook Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Rundback, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Holy Name Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacob Cynamon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Soukas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Miriam Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammad L Raja, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence Memorial Hospital - Sierra Vista Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Keith M Sterling, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inova Alexandria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Gurley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Noah Jones, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mt. Carmel East</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Kumar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Overlook Medical Center- Atlantic Center for Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laiq Raja, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence Memorial Hospital &amp; Sierra Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Kuo, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Garcia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Christiana Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baptist Health</name>
      <address>
        <city>Montgomery</city>
        <state>Alabama</state>
        <zip>36116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Medical Center</name>
      <address>
        <city>Modesto</city>
        <state>California</state>
        <zip>95355</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiana Hospital</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lakeland Regional Medical Center</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holmes Regional Medical Center</name>
      <address>
        <city>Melbourne</city>
        <state>Florida</state>
        <zip>32901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orlando Regional Medical Center</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Center of Central Georgia</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prairie Heart Institue</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky, Gill Heart Institute</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Jefferson General Hospital</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Overlook Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Name Hospital</name>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mt. Carmel East</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Memorial and Sierra Medical Center</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Alexandria Hospital</name>
      <address>
        <city>Alexandria</city>
        <state>Virginia</state>
        <zip>22304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2012</study_first_submitted>
  <study_first_submitted_qc>January 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2012</study_first_posted>
  <last_update_submitted>June 11, 2013</last_update_submitted>
  <last_update_submitted_qc>June 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fibrinolysis</keyword>
  <keyword>catheter directed fibrinolysis</keyword>
  <keyword>ultrasound accelerated fibrinolysis</keyword>
  <keyword>recombinant t-PA</keyword>
  <keyword>Activase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Plasminogen</mesh_term>
    <mesh_term>Tissue Plasminogen Activator</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

